Chemed CHE Deferred Compensation Liability (Non-Current)
Deferred Compensation Liability (Non-Current) at other companies
Other financials
Where this comes from
Reported directly by Chemed in its filing.
Tagged under the XBRL concept us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent.
The official record: Chemed’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Chemed's deferred compensation liability (non-current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Chemed's deferred compensation liability (non-current)?
- Chemed (CHE) reported deferred compensation liability (non-current) of $142.66M in Q1 2026.
- How has Chemed's deferred compensation liability (non-current) changed year-over-year?
- Chemed's deferred compensation liability (non-current) increased by 12.1% year-over-year, from $127.29M to $142.66M.
- What is the long-term trend for Chemed's deferred compensation liability (non-current)?
- Over 5 years (2020 to 2025), Chemed's deferred compensation liability (non-current) has grown at a 9.0% compound annual growth rate (CAGR), from $88.46M to $136.14M.
- What does deferred compensation liability (non-current) mean?
- This balance represents the long-term portion of obligations owed to employees under deferred compensation plans that are not expected to be settled within the next twelve months. It reflects the company's future commitment to pay out earned compensation at a later date, often tied to retirement or specific vesting conditions. This metric is essential for understanding long-term personnel-related financial obligations.